Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Martinez

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Virus Research|July 31, 2020
100 days of solitude: The spring of COVID-19 through the eyes of 15 young virologists of the INITIATE programZsofia Keszei, Xavier Martinez Vendrell, Maria Soultsioti, et al.
Medical Sciences (Basel, Switzerland)|February 20, 2026
Circulating miRNA Signatures Associated with Atherosclerosis and Cardiometabolic Comorbidities in People with HIVMarina Martinez-Velasco, José Francisco Sánchez-Herrero, Laura Ibañez, et al.
The Lancet Regional Health. Europe|May 3, 2023
Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trialJúlia Corominas, Carme Garriga, Antoni Prenafeta, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Virus Research|July 31, 2020
100 days of solitude: The spring of COVID-19 through the eyes of 15 young virologists of the INITIATE programZsofia Keszei, Xavier Martinez Vendrell, Maria Soultsioti, et al.
Medical Sciences (Basel, Switzerland)|February 20, 2026
Circulating miRNA Signatures Associated with Atherosclerosis and Cardiometabolic Comorbidities in People with HIVMarina Martinez-Velasco, José Francisco Sánchez-Herrero, Laura Ibañez, et al.
The Lancet Regional Health. Europe|May 3, 2023
Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trialJúlia Corominas, Carme Garriga, Antoni Prenafeta, et al.
Pageof 5